ロード中...
Immunotherapy for malignant glioma
Malignant gliomas (MG) are the most common type of primary malignant brain tumor. Most patients diagnosed with glioblastoma (GBM), the most common and malignant glial tumor, die within 12–15 months. Moreover, conventional treatment, which includes surgery followed by radiation and chemotherapy, can...
保存先:
| 出版年: | Surg Neurol Int |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338494/ https://ncbi.nlm.nih.gov/pubmed/25722935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.151341 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|